← All trials
NCT04551599
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 21, 2020
- Primary completion
- Jan 31, 2021
- Completion date
- Jan 31, 2021
- First posted
- Sep 16, 2020
- Last posted
- Sep 16, 2020
- Enrollment
- 32
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.